💉Biologic drugs are made up of or derived from proteins and are produced by living organisms.
🧪Biologics have a more complex manufacturing process compared to traditional drugs, leading to higher costs.
📊Biosimilars, although not identical to the innovator biologic, offer a cost-effective alternative.
⚖️Regulatory bodies have strict standards for approving biosimilars, ensuring safety and efficacy.
💰The high cost of manufacturing biologics contributes to their expensive price for consumers.
What are biologic drugs?
—Biologic drugs are a type of medication made up of or derived from proteins. They are produced by living organisms and have a more complex manufacturing process compared to traditional drugs.
How do biologics work?
—Biologics work by mimicking or replacing our own proteins to target and combat various diseases. They may trigger certain reactions in the body or disrupt disease processes.
What are biosimilars?
—Biosimilars are similar but not identical to the innovator biologic drug. They offer a cost-effective alternative to the original biologic.
Are biosimilars as effective as the innovator biologic?
—Yes, biosimilars have been shown to be as safe and effective as the innovator biologic products. They must meet rigorous safety, purity, and potency standards before being approved for use.
Why are biologics more expensive?
—The complex manufacturing process and regulatory requirements contribute to the higher cost of biologic drugs compared to traditional drugs. Additionally, the cost of bringing a biosimilar to market is also high.
00:00Biologic drugs, also known as biopharmaceuticals, are made up of or derived from proteins and are produced by living organisms.
00:37Biologic drugs have a more complex manufacturing process compared to traditional drugs, leading to higher costs.
03:19Biosimilars, although not identical to the innovator biologic, offer a cost-effective alternative.
04:44Regulatory bodies have strict standards for approving biosimilars, ensuring safety and efficacy.
06:48The high cost of manufacturing biologics contributes to their expensive price for consumers.
